Ensuring Communication in Hospice by Oncology Study (ECHO)

Mass General Brigham

Status: Completed

Conditions: Melanoma; Sarcoma; Uterine Cancer; Head and Neck Cancer; Ovarian Cancer; Cervical Cancer

Treatments: Behavioral: communication with oncology team

Study type: Interventional

Funder types: Other

Identifiers

NCT02069769

13-540

Details and patient eligibility

About

The goal of this study is to determine if scheduled communication with the oncology team through phone calls is helpful to caregivers with the transition to hospice care.

Full description

There are four parts of the study. First, the participant will receive phone calls twice a week from the oncology team to check in with how the transition to hospice is going. Second, the participant may choose to have an appointment with the Massachusetts General Hospital oncology team to discuss any questions or concerns regarding cancer care or the transition to hospice. Third, each week of hospice care, the participant will be asked to complete a set of questionnaires at a time that is convenient for them either by phone or by email. These questions will ask the participant about their recent thoughts and feelings about their experience with hospice and as a caregiver. The questions will take less than 15 minutes to answer. Fourth, after hospice care has ended, the participant will be called by the oncology team to again check in and about a month later, the participant will also be contacted by phone to complete a set of questionnaires, again asking about their thoughts and feelings about your experience with hospice and as a caregiver.

For all of the questionnaires, the participant may skip any questions that the participant prefers not to answer. The responses will remain confidential and will be available only to study staff members who are trained in confidentiality and research ethics.

Additionally, during the research study, the investigators will obtain information from the participant's loved one's Massachusetts General Hospital electronic medical record that is relevant to the participation in the study for up to 6 months. If he/she has visited another hospital during this time, the investigator will also ask the participant for their permission to obtain the medical records from this visit.

The participant will not receive any compensation for this study.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult Patient Criteria

  -->18years of age) with a diagnosis of an incurable malignancy of the head and neck, gynecological oncology, sarcoma, or melanoma

  • Receiving oncology care at the MGH Cancer Center
  • Referral to home hospice services in previous five business days.

• Family Caregiver Eligibility Criteria:

  • Designated adult family/informal caregiver for an eligible patient who will provide the primary home care for the patient receiving hospice services
  • Ability to read and respond to questions in English or with the assistance of a translator
  • Access to telephone and/or computer to communicate with the oncology team and complete questionnaires
  • Willingness to complete weekly questionnaires via telephone or email.

Exclusion criteria

• Patient Exclusion Criteria:

  -- Referral to hospice services away from home (eg in nursing home or in an inpatient or residential setting)

• Family Caregiver Exclusion Criteria --Person is not the primary caregiver for the patient

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

communication with oncology team

Experimental group

Description:

oncology team will be prompted to contact family caregiver and/or patient twice weekly while the patient is receiving hospice care.

Treatment:

Behavioral: communication with oncology team